PER 2.00% 7.4¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-859

  1. 770 Posts.
    lightbulb Created with Sketch. 131
    I acknowledge your point Uboy but there are many here including myself that see Sarepta's CR of USD$500 on top of existing bank funds of USD$1.6b as an indicator of a potential investment in ANP given their need. Timing of this, our EMA comms due and spike in interest (SO) is at the very least a consideration
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.